Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

More than seven million of UK's most vulnerable people receive COVID-19 booster jabs

Over seven million of the UK's most vulnerable people have now received their COVID-19 booster jab, the latest figures show today (Friday 29 October 2021).

29 Oct 2021

Radical decarbonization in cities has potential to dramatically improve child health, study says

Improved air quality in cities resulting from cutting carbon emissions could lead to large reductions in childhood asthma cases, premature births and incidences of babies born at an unhealthily low weight, according to a study carried out by researchers at the London School of Hygiene & Tropical Medicine.

29 Oct 2021

UK Government opens a new COVID testing center in Renfrew

The test center, located at Renfrew High Street Car Park (PA4 8QL), is part of the largest network of diagnostic testing facilities created in British history.

29 Oct 2021

SARS-CoV-2 incidence and mortality in US school opening model

Researchers reported regional variations on the impact of school reopening policy on the community rate of SARS-CoV-2 infection.

29 Oct 2021

The role of CRISPR in viral diagnostics

A comprehensive review explains in depth how CRISPR can be utilized as a reliable tool to investigate the viral life cycles.

29 Oct 2021

Unique breath test is highly accurate in identifying COVID-19 in critically ill patients

Instead of an invasive nasal swab, researchers at The Ohio State University Wexner Medical Center are exploring the use of a unique breath test for the rapid screening of patients for COVID-19.

28 Oct 2021

Breakthrough COVID infections in Northeast Italy showing waning vaccine protection

Researchers analyze an outbreak of breakthrough infections in a small nursing home in Northerneastern Italy.

28 Oct 2021

Study unravels how cells protect against influenza A viruses

Human cells use a protein named TBC1D5 to route influenza A viruses inside host cells for destruction, preventing the virus from spreading replicated copies of itself to other cells, according to a study published in Nature Microbiology.

28 Oct 2021

How long does natural or vaccine-induced immunity to COVID last?

Researchers present a comprehensive assessment on SARS-CoV-2 induced immunity.

28 Oct 2021

Understanding and predicting COVID-19 vaccination willingness of New Zealanders

The current study implemented the I3 Framework to determine the willingness of New Zealanders to be vaccinated against COVID-19.

28 Oct 2021

Structure of human-infecting canine coronavirus HuPn-2018 spike glycoprotein

As CCoV-HuPn-2018 has been recently isolated in a child's respiratory swab, researchers from the University Of Washington have been examining the structure of the virus.

28 Oct 2021

Malaria: An Interview with the World Health Organization

In this interview, we spoke to Dr. Akpaka Kalu, the World Health Organization's team leader for malaria in Africa, about the groundbreaking malaria vaccine rollout announcement.

28 Oct 2021

Panel of broadly neutralizing SARS-CoV-2 nanobodies for immune assay application

In this study, a team of researchers from Japanese institutions provide a panel of broadly neutralizing nanobodies that detect four VOCs.

28 Oct 2021

Medicare punishes 2,499 hospitals for high readmissions

The federal government's effort to penalize hospitals for excessive patient readmissions is ending its first decade with Medicare cutting payments to nearly half the nation's hospitals.

28 Oct 2021

SARS-CoV-2 vaccination lowers risk of several outcomes after breakthrough infection

Researchers at the University of Oxford have conducted a study showing that vaccination against coronavirus disease 2019 (COVID-19) is associated with a lower risk of several sequelae among those who experience breakthrough infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

28 Oct 2021